password
username
Sponsored by CakeMail, an email marketing software.
Newsletter preview

To ensure you receive MDLinx newsletters, add newsletter@newstwo.mdlinx.com to your address book

Sponsor
MDLinx Pharma
5 minutes a day to stay current.
 Newsletter
Wednesday, Aug 27, 2008
 
    Messages
Zoledronic Acid + Adjuvant Endocrine Therapy Preserves Bone Integrity In Early Breast Cancer
Today's Oncology News 
D Scott Cunningham MD, PhD, MDLinx Oncology
Novel DNA Analysis Detects Colorectal Cancer Mutations in Stool
Technology Advances 
Dorothy J. Schirf, MD, MDLinx Oncology
More Rewards for Your Reading - Updated Points Program
Stephen Smith, MDLinx
See all

 
    Articles: Biotechnology
Today: August 27, 2008
BioAlliance Pharma wins new European patent
Corporate News Releases Free Full Text   


> Subscribe to other topics

Top Read Articles This Month
1. Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimer's Disease
Lilly, 07/31/08

2. Roche's 454 Sequencing System Used to Determine the Complete Neanderthal Mitochondrial Genome, Establishing When Humans and Neanderthals Diverged
Corporate News Releases, 08/12/08

3. Delivering Drugs By Inhalation Becoming Attractive For Central Nervous System Therapeutics
PharmiWeb, 08/08/08

4. FDA Clears Test that Helps Identify Type of Cancer in Tumor Sample
FDA Press Releases , 08/01/08

5. Growth of Drug–Device Combination Products Impacting the Way Drugs are Developed
PharmiWeb, 07/30/08


> See the rest of this Month's Top Read
 
  Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb more...
 
Sponsor

Topics in Pharma
Biotechnology
Conferences/Meetings
Drug Trials
Drug/Product Approvals
Execs on the Move
Financial Reports
M&A/Partnerships
Marketing/Media/ROI
Medical Devices/Products
Physician/Patient Trends
 Popular Press
Regulatory Issues
Research & Development

When you signed up for MDLinx you requested this email be sent to you.
To manage your email address and newsletters Click Here to Login and Manage Newsletters. If you do not wish to receive this newsletter, click here to ***: ***
©2008, MDLinx, Inc.
MDLinx considers the privacy of its users to be of utmost importance and works to protect it. MDLinx uses personal user information for internal purposes only. We will not sell or share your information with outsiders. For comprehensive information about the steps that MDLinx takes to respect your privacy please read our Privacy Policy:
This email has been sent by
MDLinx, Inc. 1232 22nd Street NW
Washington, DC 20037 Tel: +1.202.293.2288 Fax: +1.202.293.1690